
Developer of cancer immune therapy designed to treat cancer
Company website ↗Total Funding
$185M
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.
Number of employees
51-100
Headquarters
Suzhou, Jiangsu, China